|
1
|
Walboomers JM, Jacobs MV, Manos MM, et al:
Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bosch FX, Manos MM, Munoz N, et al:
Prevalence of human papillomavirus in cervical cancer: a worldwide
perspective. International biological study on cervical cancer
(IBSCC) Study Group. J Natl Cancer Inst. 87:796–802. 1995.
View Article : Google Scholar
|
|
3
|
Dürst M, Gissmann L, Ikenberg H and zur
Hausen H: A papillomavirus DNA from a cervical carcinoma and its
prevalence in cancer biopsy samples from different geographic
regions. Proc Natl Acad Sci USA. 80:3812–3815. 1983.PubMed/NCBI
|
|
4
|
Bosch FX, Lorincz A, Muñoz N, Meijer CJ
and Shah KV: The causal relation between human papillomavirus and
cervical cancer. J Clin Pathol. 55:244–265. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Morris M, Eifel PJ, Lu J, et al: Pelvic
radiation with concurrent chemotherapy compared with pelvic and
para-aortic radiation for high-risk cervical cancer. N Engl J Med.
340:1137–1143. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Isacson C, Kessis TD, Hedrick L and Cho
KR: Both cell proliferation and apoptosis increase with lesion
grade in cervical neoplasia but do not correlate with human
papillomavirus type. Cancer Res. 56:669–674. 1996.PubMed/NCBI
|
|
7
|
Tsang RW, Fyles AW, Li Y, et al: Tumor
proliferation and apoptosis in human uterine cervix carcinoma I:
correlations between variables. Radiother Oncol. 50:85–92. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lo HW, Hsu SC, Ali-Seyed M, et al: Nuclear
interaction of EGFR and STAT3 in the activation of the iNOS/NO
pathway. Cancer Cell. 7:575–589. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kroll J and Waltenberger J: VEGF-A induces
expression of eNOS and iNOS in endothelial cells via VEGF
receptor-2 (KDR). Biochem Biophys Res Commun. 252:743–746. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ichinoe M, Mikami T, Shiraishi H and
Okayasu I: High microvascular density is correlated with high VEGF,
iNOS and COX-2 expression in penetrating growth-type early gastric
carcinomas. Histopathology. 45:612–618. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang J and Peng B: NF-kappaB promotes
iNOS and VEGF expression in salivary gland adenoid cystic carcinoma
cells and enhances endothelial cell motility in vitro. Cell
Prolif. 42:150–161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saura M, Zaragoza C, McMillan A, et al: An
antiviral mechanism of nitric oxide: inhibition of a viral
protease. Immunity. 10:21–28. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kostourou V, Cartwright JE, Johnstone AP,
et al: The role of tumour-derived iNOS in tumour progression and
angiogenesis. Br J Cancer. 104:83–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Benjamin LE, Hemo I and Keshet E: A
plasticity window for blood vessel remodelling is defined by
pericyte coverage of the preformed endothelial network and is
regulated by PDGF-B and VEGF. Development. 125:1591–1598. 1998.
|
|
15
|
Holash J, Davis S, Papadopoulos N, et al:
VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl
Acad Sci USA. 99:11393–11398. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng CW, Wang LD, Jiao LH, Liu B, Zheng S
and Xie XJ: Expression of p53, inducible nitric oxide synthase and
vascular endothelial growth factor in gastric precancerous and
cancerous lesions: correlation with clinical features. BMC Cancer.
2:82002. View Article : Google Scholar
|
|
17
|
Chiarugi V, Magnelli L and Gallo O: Cox-2,
iNOS and p53 as play-makers of tumor angiogenesis (review). Int J
Mol Med. 2:715–724. 1998.PubMed/NCBI
|
|
18
|
Martínez-Estrada OM, Rodríguez-Millán E,
González-De Vicente E, Reina M, Vilaró S and Fabre M:
Erythropoietin protects the in vitro blood-brain barrier
against VEGF-induced permeability. Eur J Neurosci. 18:2538–2544.
2003.
|
|
19
|
Fukumura D and Jain RK: Tumor
microvasculature and microenvironment: targets for
anti-angiogenesis and normalization. Microvasc Res. 74:72–84. 2007.
View Article : Google Scholar : PubMed/NCBI
|
